Anthony H Nguyen

Array ( [id] => 1129958 [patent_doc_number] => 06787303 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis' [patent_app_type] => B1 [patent_app_number] => 09/536552 [patent_app_country] => US [patent_app_date] => 2000-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17524 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787303.pdf [firstpage_image] =>[orig_patent_app_number] => 09536552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1108541 [patent_doc_number] => 06809239 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Choline monooxygenase gene' [patent_app_type] => B1 [patent_app_number] => 09/534995 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15437 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809239.pdf [firstpage_image] =>[orig_patent_app_number] => 09534995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257268 [patent_doc_number] => 06258563 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Increasing production of proteins in gram-positive microorganisms' [patent_app_type] => 1 [patent_app_number] => 9/462844 [patent_app_country] => US [patent_app_date] => 2000-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 34 [patent_no_of_words] => 13308 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258563.pdf [firstpage_image] =>[orig_patent_app_number] => 462844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4281920 [patent_doc_number] => 06267956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Protein activator and apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/531914 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22073 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/267/06267956.pdf [firstpage_image] =>[orig_patent_app_number] => 531914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870118 [patent_doc_number] => 20030082807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Xylo-LNA analogues' [patent_app_type] => new [patent_app_number] => 09/528110 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23111 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082807.pdf [firstpage_image] =>[orig_patent_app_number] => 09528110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288117 [patent_doc_number] => 06211164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Antisense oligonucleotides of the human chk1 gene and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/522800 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5357 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211164.pdf [firstpage_image] =>[orig_patent_app_number] => 522800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4339122 [patent_doc_number] => 06333408 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Oligonucleotides inhibitors of PAI-1 MRNA' [patent_app_type] => 1 [patent_app_number] => 9/521617 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6167 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333408.pdf [firstpage_image] =>[orig_patent_app_number] => 521617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414850 [patent_doc_number] => 06528702 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Plant genes and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/519232 [patent_app_country] => US [patent_app_date] => 2000-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528702.pdf [firstpage_image] =>[orig_patent_app_number] => 09519232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432315 [patent_doc_number] => 07265088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-04 [patent_title] => 'Method and compositions for altering mucus secretion' [patent_app_type] => utility [patent_app_number] => 09/914020 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 14554 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265088.pdf [firstpage_image] =>[orig_patent_app_number] => 09914020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151584 [patent_doc_number] => 07683035 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-03-23 [patent_title] => 'Method of stabilizing and/or isolating nucleic acids' [patent_app_type] => utility [patent_app_number] => 09/510534 [patent_app_country] => US [patent_app_date] => 2000-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 16755 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/683/07683035.pdf [firstpage_image] =>[orig_patent_app_number] => 09510534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313380 [patent_doc_number] => 06613960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Phloem-loading-specific promoter' [patent_app_type] => B1 [patent_app_number] => 09/503890 [patent_app_country] => US [patent_app_date] => 2000-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 17 [patent_no_of_words] => 13578 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613960.pdf [firstpage_image] =>[orig_patent_app_number] => 09503890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082957 [patent_doc_number] => 06833348 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-21 [patent_title] => 'Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways' [patent_app_type] => B1 [patent_app_number] => 09/403861 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 18 [patent_no_of_words] => 27760 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833348.pdf [firstpage_image] =>[orig_patent_app_number] => 09403861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668524 [patent_doc_number] => 07094765 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'Antisense restenosis composition and method' [patent_app_type] => utility [patent_app_number] => 09/493427 [patent_app_country] => US [patent_app_date] => 2000-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 8415 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094765.pdf [firstpage_image] =>[orig_patent_app_number] => 09493427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1594116 [patent_doc_number] => 06383812 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Anti liver disease drug R-YEEE and method of synthesizing branched galactose-terminal glycoproteins' [patent_app_type] => B1 [patent_app_number] => 09/490734 [patent_app_country] => US [patent_app_date] => 2000-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2692 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383812.pdf [firstpage_image] =>[orig_patent_app_number] => 09490734 [rel_patent_id] =>[rel_patent_doc_number] =>)